CELH
Celsius Holdings, Inc.
CELH has the edge over FLO overall, supported by stronger modeled upside and stronger valuation.
FLO
Flowers Foods, Inc.
FLO trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
FLO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
FLO's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over FLO in the historical PE scenario, which offers more potential upside but is not a forecast.
FLO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.3x | $6.01 | — |
| Cheap | 18x | $2.57 | -57% |
| Fair | 26x | $3.60 | -40% |
| Expensive | 38x | $5.35 | -11% |
| Current | 43x | $6.01 | — |
Historical ranges are pointers, not guarantees.
FLO's PE is in its expensive range at 43x. If earnings grow as analysts expect, today's price would be 8.3x next year's earnings, in its cheap range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over FLO on the outlook, with more favorable revenue and profitability expectations.
FLO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect FLO's earnings to grow, with its revenue and profitability holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
FLO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.72 | +417% |
| Q3 2026 | $0.14 | -85% |
| Q3 2026 | $0.26 | -75% |
| Q2 2026 | $0.35 | -68% |
| Q4 2025 | $0.40 | -66% |
| Q3 2025 | $0.92 | -19% |
| Q2 2025 | $1.04 | +70% |
| Q2 2025 | $1.08 | +83% |
| Q4 2024 | $1.17 | +102% |
FLO has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over FLO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over FLO on profitability, with a higher operating margin.
FLO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | -4.7% |
| Q3 2026 | $1.2B | -4% |
| Q2 2026 | $1.6B | +1.1% |
| Q4 2025 | $1.2B | +11% |
| Q3 2025 | $1.2B | +3% |
| Q2 2025 | $1.2B | +1.5% |
| Q2 2025 | $1.6B | -1.4% |
| Q4 2024 | $1.1B | -1.6% |
FLO's revenue fell from its 2024 peak and has held roughly level since: $1.2B last quarter, down 4.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.8% | -2.7 points |
| Q3 2026 | 5.7% | -1.8 points |
| Q2 2026 | 5.1% | -0.4 points |
| Q4 2025 | -5.8% | -11 points |
| Q3 2025 | 5.4% | -2.2 points |
| Q2 2025 | 7.5% | -0.3 points |
| Q2 2025 | 5.5% | -1 points |
| Q4 2024 | 5.5% | +1.1 points |
FLO's operating margin was 2.8% last quarter, down 2.7 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
FLO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $58.3M | +92% |
| Q3 2026 | $109.8M | +9.8% |
| Q2 2026 | $87.2M | -21% |
| Q4 2025 | $78.6M | -7.4% |
| Q3 2025 | $30.4M | -66% |
| Q2 2025 | $100M | +183% |
| Q2 2025 | $110.1M | +53% |
| Q4 2024 | $84.8M | +41% |
FLO has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over FLO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
FLO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +179K shares |
| 1 year | +0.3% | +565K shares |
| 3 years | +0.5% | +1.1M shares |
| 5 years | -0.2% | -515K shares |
| Available history | +0.3% | +698K shares |
FLO has 213M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $105,000 |
| Q3 2026 | $37,000 |
| Q2 2026 | $3.8M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q2 2025 | $5.5M |
| Q4 2024 | — |
FLO spent $4M buying back its own shares over the past year, down 29% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over FLO on leverage, with a lower net debt burden relative to earnings.
FLO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.8x | High |
| Q3 2026 | 5.2x | High |
| Q2 2026 | 5.1x | High |
| Q4 2025 | 5.1x | High |
| Q3 2025 | 3.7x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q2 2025 | 3.6x | Elevated |
| Q4 2024 | 2.0x | Moderate |
FLO's net debt is about 5.8 years of its operating earnings (EBITDA), up from 3.7 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
FLO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.6 | Neutral |
| Stochastic | 40.0 | Neutral |
FLO's weekly RSI is 38 (neutral) and its Stochastic is 40 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over FLO on valuation relative to its sector.
FLO PE vs Consumer Defensive Sector
| Metric | FLO | Sector median | Relative |
|---|---|---|---|
| PE | 43x | 19x | 120% above |
| PE % | 89 | 18 | 71 pts above |
FLO is trading at 43x earnings, a 120% premium to the Consumer Defensive sector's median of 19x.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over FLO on trend strength, trading above more of its moving averages.
FLO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.05 | 0.7% below |
| 20 week MA | $6.79 | 11% below |
| 50 week MA | $8.31 | 28% below |
| 100 week MA | $12.3 | 51% below |
| 200 week MA | $18.1 | 67% below |
FLO is in a downtrend: it's below all five of its weekly moving averages, and 67% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over FLO on returns for 2026, with the stronger performance.
FLO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.7 | $23.2 | +6.5% |
| 2021 | $23.2 | $26.9 | +16% |
| 2022 | $26.9 | $29.2 | +8.6% |
| 2023 | $29.2 | $22.5 | -23% |
| 2024 | $22.5 | $20.5 | -9.1% |
| 2025 | $20.5 | $10.9 | -47% |
| 2026 YTD | $10.9 | $6.01 | -45% |
FLO has finished three years in a row lower, and it's down 45% so far in 2026.